FDAnews Drug Daily Bulletin

PHYTOMEDICAL'S NEW DIABETES COMPOUNDS UNIQUE FROM ALL EXISTING DRUGS

April 26, 2006
A A

PhytoMedical Technologies, Inc. today announced its research into novel, insulin enhancing treatments will actively focus on the development of a new class of specific 'polyphenolic' compounds which possess unique antioxidant and insulin enhancing qualities, distinct from existing classes of drugs for diabetes.
Business Wire